Kenya

in page functions
[French]
Kenya
Total population (2017) 48,466,763
Birth cohort (2017) 1,601,353
Surviving Infants (surviving to 1 year per year, 2017) 1,523,809
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 36/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 49/1000
World Bank Index, IDA (2015) 3.82
Gross Nation Income (per capita US$, 2015) 1,340
Co-financing group (2017) Preparatory transition
No. of districts/territories (2015) 299

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Kenya

Type of support

Approvals

2001-2021 (US$)
(29 Jun 2017)

Commitments

2001-2021 (US$)
(29 Jun 2017)

Disbursements

2000-2017 (US$)
(29 Jun 2017)

% Disbursed

(29 Jun 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $443,971,146 $455,083,367 $440,167,087
Cash Support (CASHSUPP) $348,000 $348,000 $145,000 42%
Cold Chain Equipment Optimisation Platform (CCEOP) $4,115,870 $4,115,870
Health system strengthening (HSS 1) $8,334,292 $8,334,292 $8,334,292 100%
Health system strengthening (HSS 2) $9,227,739 $20,339,960 $4,554,875 49%
HPV Demo (NVS) $714,749 $714,749 $269,399 38%
Immunisation services support (ISS) $6,384,766 $6,384,766 $6,384,766 100%
Injection Safety Devices (NVS) $518,000 $518,000 $678,620 131%
Injection safety support (INS) $1,129,963 $1,129,963 $1,129,963 100%
IPV (NVS) $4,128,862 $4,128,862 $2,877,291 70%
Measles-Rubella (NVS) $13,513,824 $13,513,824 $13,513,824 100%
MR - Operational costs (OPC) $12,332,500 $12,332,500 $12,332,500 100%
Penta (NVS) $170,681,416 $170,681,416 $166,433,334 98%
Pneumo (NVS) $185,027,573 $185,027,573 $198,031,467 107%
Rotavirus (NVS) $22,708,182 $22,708,182 $20,678,195 91%
Vaccine Introduction Grant (VIG) $4,282,500 $4,282,500 $4,282,500 100%
Yellow Fever (NVS) $522,910 $522,910 $521,061 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Kenya DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 78%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2013) 89.60%
Household survey: DTP3 coverage for female (2013) 90.20%
Household survey: Last DTP3 survey (2013) 90%
% districts achieving > 80% DTP3 coverage (2015) 35%
% districts achieving < 50% DTP3 coverage (2015) 5%
MCV WHO/UNICEF estimates (2016) 75%

Breakdown of support

Non-vaccine support Vaccine support
8% 92%
$37,163,896 $403,003,191

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Kenya

26 May 2017

Julia Roberts talks to young boys in Kenya during a special edition of “Running Wild”

Red Nose Day USA went 'Running Wild' for vaccines

Julia Roberts and Bear Grylls documentary about immunisation supply chain featured in 2017 telethon.

23 May 2017

Seth Q&A

Big Ideas: Gavi CEO Seth Berkley’s Q&A, Part II

Ahead of Seth Berkley’s speech to the 2017 graduating class at Johns Hopkins University in Washington, DC on 23 June, Global Health published a two-part Q&A with the Gavi CEO. In this second article, Seth shares his concerns about the expansion of the vaccine hesitancy movement, explains why digital identity technologies in low- and middle-income countries can help improve vaccine coverage, and discusses the value of testing the potentially important malaria vaccine.

24 April 2017

Mosquito malaria

Partnership supports launch of malaria vaccine pilots in three African countries

Funders hail next step in the development of world’s first malaria vaccine.

close icon

modal window here